ArticleBMC psychiatry2026
Who's at risk for emergent depression years later? Predictive modeling in a nine-year longitudinal cohort.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMajor depressive disorder (MDD) is prevalent in adulthood, but there remains a dearth of studies identifying predictors of emergent MDD in adulthood with high-dimensional biopsychosocial predictor sets. Our study thus examined how explainable artificial intelligence (XAI) models might accurately detect predictors of emergent MDD nine years later.
methodsCommunity adults who did not meet diagnostic criteria for MDD at Wave 1 (W1; 2004–2006) participated in the current study (N = 931). Forty-six W1 validated composite variables, including inflammation, childhood maltreatment, coping, emotion regulation, personality, and social support, were used to predict emergent MDD at Wave 2 (W2; 2013–2014). Six machine-learning models, each with four varying configurations of predictor set length and missingness handling strategies, were tested using five-fold nested cross-validation to determine which model had the best multivariable predictive performance. Shapley additive explanations (SHAP) analysis informed the sign and strength of each multivariable predictor.
resultsElastic net regression achieved the best classification accuracy (AUC = 0.724; 95% confidence intervals = 0.657–0.792), with moderate sensitivity and a high negative predictive value in predicting W2 emergent MDD, observed in 6.23% of the sample. Moderate-to-good calibration values were also observed, highlighting acceptable alignment between predicted probabilities and observed prevalences. Key psychosocial correlates of higher W2 emergent MDD risk included greater perceived stress, early life minimization and stress, as well as family and spousal strain. Other key correlates included fewer problem-focused coping strategies, lower self-acceptance, sense of control, and self-directedness, as well as greater tendencies for behavioral disengagement. Demographic correlates included younger age and racial minority identity. Comorbid mental health symptoms, especially higher W1 generalized anxiety disorder, panic disorder, and substance use disorder symptom severity, were also clinical correlates of greater W2 emergent MDD risk.
conclusionsXAI may inform clinically actionable distal risk modeling for emergent MDD using easily measurable, theory-driven variables. If externally validated, scalable multivariable predictive models could be integrated into healthcare systems to inform prevention strategies. These predictive models might inform tailored treatment strategies, including enhancing approach-focused coping, emotion regulation, and appraisals, as well as objective indicators of social support and stress. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.